Tirzepatide 40 mg — Research Grade (Bulk Vial)
Tirzepatide is a dual-agonist research peptide that activates both the GLP-1 and GIP receptors. This dual incretin mechanism is extensively studied in metabolic, glucose-regulation, and body-weight research models. This 40 mg bulk vial supports laboratories requiring larger quantities for extended studies. Supplied as a lyophilized powder for controlled laboratory research only.
Specifications
- Compound: Tirzepatide (dual agonist — GLP-1 / GIP)
- Quantity: 40 mg per vial, lyophilized powder (bulk)
- Purity: 99%+ HPLC standard — batch-specific Certificate of Analysis included for your exact lot
- Identity: confirmed by LC-MS
- Appearance: white lyophilized powder
Documentation: Every vial ships with access to a batch-specific Certificate of Analysis showing HPLC purity, mass-spectrometry identity confirmation, endotoxin, residual solvents, and water content for your exact lot.
Handling & storage: Store lyophilized powder at -20°C. Reconstitute with bacteriostatic water for research handling. Keep out of direct light.
For laboratory and research use only. Not for human or animal consumption.





Reviews
No reviews yet — be the first. Every batch is independently third-party tested by Freedom Diagnostics, with a Certificate of Analysis on file.